Press Releases INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Market Closed - Nasdaq Other stock markets 04:30:01 2024-04-26 pm EDT			5-day change	1st Jan Change
0.98 ^USD	-0.01%		-28.47%	-27.41%

Apr. 18	Top Premarket Decliners	MT
Apr. 17	Sector Update: Health Care Stocks Retreating Late Afternoon	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	Apr. 22	AQ
INVO Reports Fourth Quarter and Full Year 2023 Financial Results	Apr. 16	AQ
INVO Bioscience : Reports Fourth Quarter and Full Year 2023 Financial Results - Form 8-K	Apr. 16	PU
INVO Bioscience : Private Placement - Form 8-K	Apr. 01	PU
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors	Jan. 17	AQ
INVO Bioscience : Submission of Matters to a Vote of Security Holders - Form 8-K	Dec. 28	PU
NAYA Biosciences Announces Publication Of New Data For Its CD38-Targeted Flex-NK Bispecific Antibody in The American Society of Hematology s Blood Journal	Dec. 12	AQ
INVO Bioscience, Inc. - NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK Bispecific Antibodies and Optimally Engineered Off-The-Shelf Natural Killer Cell Therapies	Dec. 07	AQ
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement	Nov. 29	AQ
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement	Nov. 28	PR
INVO Reports Record Third Quarter 2023 Financial Results	Nov. 13	PR
BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger	Nov. 13	AQ
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger	Nov. 10	PR
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants	Nov. 09	PR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSTR, INVO, NM	23-10-31	PR
INVO BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of INVO Bioscience, Inc. - INVO	23-10-24	BU
Shareholder Alert: Ademi LLP investigates whether INVO Bioscience, Inc. has obtained a Fair Price in its transaction with NAYA Biosciences	23-10-23	PR
INVO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of INVO Bioscience, Inc. Is Fair to Shareholders	23-10-23	BU
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company	23-10-23	PR
INVO to Participate in the Lytham Partners Fall 2023 Investor Conference	23-10-11	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Press Releases

Filters